Table 2

Hazard ratios and 95% confidence intervals of MACCE, all-cause mortality, myocardial infarction, stroke, and revascularization by smoking status

Events
(n)
Follow-up
duration (person-years)
Incidence rate
(per 1000 person-years)
Unadjusted
HR (95% CI)
Multivariable model 1
HR (95% CI)
Multivariable model 2
HR (95% CI)
IPW-adjusted HR (95% CI)
MACCE
 Non-smokers6713124 01754.1301 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers5217102 48250.907.936 (.902–.970)1.035 (.991–1.080)1.036 (.992–1.081)1.084 (1.047–1.123)
 Current smokers247842 15758.7811.078 (1.030–1.129)1.226 (1.164–1.292)1.198 (1.137–1.263)1.191 (1.138–1.245)
Death
 Non-smokers2177139 30415.6281 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers1382114 91412.026.774 (.723–.828)1.090 (1.008–1.178)1.080 (.999–1.168)1.354 (1.271–1.441)
 Current smokers78147 55416.4231.060 (.977–1.150)1.658 (1.513–1.817)1.606 (1.465–1.760)1.660 (1.540–1.790)
Myocardial infarction
 Non-smokers612137 8054.4411 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers626113 2265.5291.242 (1.111–1.389)1.216 (1.065–1.388)1.155 (1.011–1.318)1.099 (.983–1.228)
 Current smokers36746 6687.8641.768 (1.554–2.013)1.721 (1.482–1.998)1.560 (1.343–1.812)1.557 (1.367–1.772)
Stroke
 Non-smokers1197136 6488.7601 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers660113 4225.819.665 (.605–.731).960 (.857–1.074).954 (.852–1.068).949 (.866–1.041)
 Current smokers33246 8857.081.810 (.717–.915)1.263 (1.101–1.449)1.225 (1.068–1.406)1.176 (1.049–1.317)
Revascularization
 Non-smokers4159126 22132.9501 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers3663103 73835.3101.060 (1.014–1.108)1.019 (.966–1.074)1.028 (.975–1.084)1.018 (.975–1.064)
 Current smokers163042 70638.1681.142 (1.078–1.209)1.090 (1.022–1.163)1.078 (1.010–1.150)1.043 (.985–1.105)
Events
(n)
Follow-up
duration (person-years)
Incidence rate
(per 1000 person-years)
Unadjusted
HR (95% CI)
Multivariable model 1
HR (95% CI)
Multivariable model 2
HR (95% CI)
IPW-adjusted HR (95% CI)
MACCE
 Non-smokers6713124 01754.1301 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers5217102 48250.907.936 (.902–.970)1.035 (.991–1.080)1.036 (.992–1.081)1.084 (1.047–1.123)
 Current smokers247842 15758.7811.078 (1.030–1.129)1.226 (1.164–1.292)1.198 (1.137–1.263)1.191 (1.138–1.245)
Death
 Non-smokers2177139 30415.6281 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers1382114 91412.026.774 (.723–.828)1.090 (1.008–1.178)1.080 (.999–1.168)1.354 (1.271–1.441)
 Current smokers78147 55416.4231.060 (.977–1.150)1.658 (1.513–1.817)1.606 (1.465–1.760)1.660 (1.540–1.790)
Myocardial infarction
 Non-smokers612137 8054.4411 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers626113 2265.5291.242 (1.111–1.389)1.216 (1.065–1.388)1.155 (1.011–1.318)1.099 (.983–1.228)
 Current smokers36746 6687.8641.768 (1.554–2.013)1.721 (1.482–1.998)1.560 (1.343–1.812)1.557 (1.367–1.772)
Stroke
 Non-smokers1197136 6488.7601 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers660113 4225.819.665 (.605–.731).960 (.857–1.074).954 (.852–1.068).949 (.866–1.041)
 Current smokers33246 8857.081.810 (.717–.915)1.263 (1.101–1.449)1.225 (1.068–1.406)1.176 (1.049–1.317)
Revascularization
 Non-smokers4159126 22132.9501 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers3663103 73835.3101.060 (1.014–1.108)1.019 (.966–1.074)1.028 (.975–1.084)1.018 (.975–1.064)
 Current smokers163042 70638.1681.142 (1.078–1.209)1.090 (1.022–1.163)1.078 (1.010–1.150)1.043 (.985–1.105)

CI, confidence interval; HR, hazard ratio; IPW, inverse probability-weighted; MACCE, major adverse cardiovascular and cerebrovascular events.

Multivariable model 1: HRs are adjusted for age, sex, hypertension, diabetes mellitus, dyslipidaemia, body mass index, social income, regular exercise, and alcohol drinking status.

Multivariable model 2: HRs are adjusted for age, sex, hypertension, diabetes mellitus, dyslipidaemia, body mass index, social income, regular exercise, alcohol drinking status, myocardial infarction, heart failure, aspirin, clopidogrel, potent P2Y12 inhibitors, and statin.

IPW model: weights are calculated by age, sex, hypertension, diabetes mellitus, dyslipidaemia, body mass index, social income, regular exercise, alcohol drinking status, myocardial infarction, heart failure, aspirin, clopidogrel, potent P2Y12 inhibitors, and statin.

Table 2

Hazard ratios and 95% confidence intervals of MACCE, all-cause mortality, myocardial infarction, stroke, and revascularization by smoking status

Events
(n)
Follow-up
duration (person-years)
Incidence rate
(per 1000 person-years)
Unadjusted
HR (95% CI)
Multivariable model 1
HR (95% CI)
Multivariable model 2
HR (95% CI)
IPW-adjusted HR (95% CI)
MACCE
 Non-smokers6713124 01754.1301 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers5217102 48250.907.936 (.902–.970)1.035 (.991–1.080)1.036 (.992–1.081)1.084 (1.047–1.123)
 Current smokers247842 15758.7811.078 (1.030–1.129)1.226 (1.164–1.292)1.198 (1.137–1.263)1.191 (1.138–1.245)
Death
 Non-smokers2177139 30415.6281 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers1382114 91412.026.774 (.723–.828)1.090 (1.008–1.178)1.080 (.999–1.168)1.354 (1.271–1.441)
 Current smokers78147 55416.4231.060 (.977–1.150)1.658 (1.513–1.817)1.606 (1.465–1.760)1.660 (1.540–1.790)
Myocardial infarction
 Non-smokers612137 8054.4411 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers626113 2265.5291.242 (1.111–1.389)1.216 (1.065–1.388)1.155 (1.011–1.318)1.099 (.983–1.228)
 Current smokers36746 6687.8641.768 (1.554–2.013)1.721 (1.482–1.998)1.560 (1.343–1.812)1.557 (1.367–1.772)
Stroke
 Non-smokers1197136 6488.7601 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers660113 4225.819.665 (.605–.731).960 (.857–1.074).954 (.852–1.068).949 (.866–1.041)
 Current smokers33246 8857.081.810 (.717–.915)1.263 (1.101–1.449)1.225 (1.068–1.406)1.176 (1.049–1.317)
Revascularization
 Non-smokers4159126 22132.9501 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers3663103 73835.3101.060 (1.014–1.108)1.019 (.966–1.074)1.028 (.975–1.084)1.018 (.975–1.064)
 Current smokers163042 70638.1681.142 (1.078–1.209)1.090 (1.022–1.163)1.078 (1.010–1.150)1.043 (.985–1.105)
Events
(n)
Follow-up
duration (person-years)
Incidence rate
(per 1000 person-years)
Unadjusted
HR (95% CI)
Multivariable model 1
HR (95% CI)
Multivariable model 2
HR (95% CI)
IPW-adjusted HR (95% CI)
MACCE
 Non-smokers6713124 01754.1301 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers5217102 48250.907.936 (.902–.970)1.035 (.991–1.080)1.036 (.992–1.081)1.084 (1.047–1.123)
 Current smokers247842 15758.7811.078 (1.030–1.129)1.226 (1.164–1.292)1.198 (1.137–1.263)1.191 (1.138–1.245)
Death
 Non-smokers2177139 30415.6281 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers1382114 91412.026.774 (.723–.828)1.090 (1.008–1.178)1.080 (.999–1.168)1.354 (1.271–1.441)
 Current smokers78147 55416.4231.060 (.977–1.150)1.658 (1.513–1.817)1.606 (1.465–1.760)1.660 (1.540–1.790)
Myocardial infarction
 Non-smokers612137 8054.4411 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers626113 2265.5291.242 (1.111–1.389)1.216 (1.065–1.388)1.155 (1.011–1.318)1.099 (.983–1.228)
 Current smokers36746 6687.8641.768 (1.554–2.013)1.721 (1.482–1.998)1.560 (1.343–1.812)1.557 (1.367–1.772)
Stroke
 Non-smokers1197136 6488.7601 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers660113 4225.819.665 (.605–.731).960 (.857–1.074).954 (.852–1.068).949 (.866–1.041)
 Current smokers33246 8857.081.810 (.717–.915)1.263 (1.101–1.449)1.225 (1.068–1.406)1.176 (1.049–1.317)
Revascularization
 Non-smokers4159126 22132.9501 (ref)1 (ref)1 (ref)1 (ref)
 Ex-smokers3663103 73835.3101.060 (1.014–1.108)1.019 (.966–1.074)1.028 (.975–1.084)1.018 (.975–1.064)
 Current smokers163042 70638.1681.142 (1.078–1.209)1.090 (1.022–1.163)1.078 (1.010–1.150)1.043 (.985–1.105)

CI, confidence interval; HR, hazard ratio; IPW, inverse probability-weighted; MACCE, major adverse cardiovascular and cerebrovascular events.

Multivariable model 1: HRs are adjusted for age, sex, hypertension, diabetes mellitus, dyslipidaemia, body mass index, social income, regular exercise, and alcohol drinking status.

Multivariable model 2: HRs are adjusted for age, sex, hypertension, diabetes mellitus, dyslipidaemia, body mass index, social income, regular exercise, alcohol drinking status, myocardial infarction, heart failure, aspirin, clopidogrel, potent P2Y12 inhibitors, and statin.

IPW model: weights are calculated by age, sex, hypertension, diabetes mellitus, dyslipidaemia, body mass index, social income, regular exercise, alcohol drinking status, myocardial infarction, heart failure, aspirin, clopidogrel, potent P2Y12 inhibitors, and statin.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close